{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:57:14Z","timestamp":1781233034083,"version":"3.54.1"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Robert C. Hickey Chair in Clinical Care Endowment"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The prognosis of mucormycosis after hematopoietic stem cell transplantation (HSCT) is generally poor but data on post-HSCT outcomes in patients with pre-HSCT mucormycosis are limited. We reviewed patients with documented mucormycosis at MD Anderson Cancer Center (2008\u20132024) and identified five patients who subsequently underwent HSCT. A literature review identified 24 additional such cases. Most patients had acute myeloid leukemia (69%). The most common site of mucormycosis was pulmonary (59%), while 31% had disseminated mucormycosis. All patients received antifungals and 76% had surgery prior to HSCT. At the time of HSCT, 67% had mucormycosis responding to treatment. No patient went to transplant with progressing mucormycosis. Eighty percent of patients with \u226512 months of follow-up after HSCT were alive. Five of the twenty-nine patients (17%) had documented or suspected mucormycosis recurrence post-HSCT. Relapsed malignancy pre-HSCT was associated with increased 12-month post-HSCT mortality (p = 0.031). Furthermore, post-transplant mortality was higher in cord blood recipients (p = 0.019) and tended to be higher in patients not undergoing surgery pre-HSCT (p = 0.062). Despite publication bias, our data suggest that HSCT can be conducted safely in selected patients with pre-HSCT mucormycosis, particularly when underlying hematologic malignancy is in remission, mucormycosis is stable, and surgical source control is feasible.<\/jats:p>","DOI":"10.3390\/jof12060423","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:52:08Z","timestamp":1781229128000},"page":"423","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can Patients with Hematologic Disease and Prior Mucormycosis Undergo Stem Cell Transplantation?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-552X","authenticated-orcid":false,"given":"Armando","family":"Leon","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-5671","authenticated-orcid":false,"given":"Rachel S.","family":"Hicklen","sequence":"additional","affiliation":[{"name":"Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam G.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-7256","authenticated-orcid":false,"given":"Sebastian","family":"Wurster","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8051-2940","authenticated-orcid":false,"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001\u20132006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","first-page":"194","article-title":"American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients","volume":"31","author":"Douglas","year":"2025","journal-title":"Transpl. Cell Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mmcr.2019.01.001","article-title":"Successful treatment of severe aplastic anemia with syngeneic stem cell transplantation in the setting of active disseminated mucormycosis","volume":"23","author":"Atoui","year":"2019","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1399-3062.2009.00484.x","article-title":"Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection","volume":"12","author":"Lebeau","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"A629","DOI":"10.1016\/j.chest.2019.08.615","article-title":"Pulmonary Mucormycosis Treated with Combination Antifungals and Lobectomy Prior to Stem Cell Transplant in a Patient with AML","volume":"156","author":"Amin","year":"2019","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e29960","DOI":"10.1002\/pbc.29960","article-title":"Successful stem cell transplantation in two children with acute leukemia and disseminated, non-resectable Mucorales infection prior to transplantation","volume":"70","author":"Beudeker","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jiac.2019.08.003","article-title":"Surgical resection for persistent localized pulmonary fungal infection prior to allogeneic hematopoietic stem cell transplantation: Analysis of six cases","volume":"26","author":"Harada","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102790","DOI":"10.1016\/j.jiac.2025.102790","article-title":"Successful allogeneic hematopoietic stem cell transplantation for AML with pulmonary mucormycosis under isavuconazole","volume":"31","author":"Hosoda","year":"2025","journal-title":"J. Infect. Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2169\/internalmedicine.53.1366","article-title":"Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia","volume":"53","author":"Yuda","year":"2014","journal-title":"Intern Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ped.12866","article-title":"Stem cell transplantation for acute myeloid leukemia with pulmonary and cerebral mucormycosis","volume":"58","author":"Suzuki","year":"2016","journal-title":"Pediatr. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/acr.2019.11.02","article-title":"Pulmonary mucormycosis developed during acute myelogenous leukemia and successfully treated by surgical resection before blood stem cell transplantation","volume":"3","author":"Miura","year":"2019","journal-title":"AME Case Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1705655","article-title":"Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia","volume":"39","author":"Nosari","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mmcr.2017.07.002","article-title":"Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis","volume":"18","author":"Ochi","year":"2017","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e70125","DOI":"10.1002\/jha2.70125","article-title":"Successful Allogeneic Stem Cell Transplant for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia After Pneumonectomy for Pulmonary Mucormycosis: A Case Report and Review of the Literature","volume":"6","author":"Zepcan","year":"2025","journal-title":"eJHaem"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pbc.20994","article-title":"Invasive rhino-maxillary mucormycosis diagnosed before HSCT","volume":"50","author":"Piccin","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2169\/internalmedicine.3314-19","article-title":"A Radical Approach to Acute Lymphoblastic Leukemia Treatment: A Case Study of a Veterinarian Specializing in Livestock who Developed Disseminated Mucormycosis during Induction Therapy","volume":"59","author":"Sakai","year":"2020","journal-title":"Intern Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1111\/tid.12019","article-title":"Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis","volume":"14","author":"Schneidawind","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"ref_22","first-page":"362","article-title":"Disseminated Mucormycosis and T-Cell-Depleted Allogeneic Stem Cell Transplantation: An Unusual Case Study","volume":"148","author":"Dragoi","year":"2025","journal-title":"Acta Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/10428190290006305","article-title":"Successful allogeneic stem cell transplant after invasive pulmonary zygomycosis","volume":"43","author":"Slavin","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/10428190290012236","article-title":"Prior invasive pulmonary and cerebellar mucormycosis is not a primary contraindication to perform an autologous stem cell transplatation in leukemia","volume":"43","author":"Tedeschi","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1007\/s12070-024-04610-1","article-title":"Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis","volume":"76","author":"Zhumatayev","year":"2024","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"ref_26","first-page":"1183","article-title":"Autologous peripheral blood stem cell transplantation in a patient with previous invasive middle ear mucormycosis","volume":"18","author":"Olalla","year":"1996","journal-title":"Bone Marrow Transpl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/cid\/ciae613","article-title":"Glucocorticoid Dosing and Implications for Vaccination: Evolution of Global Definitions","volume":"80","author":"Wang","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","unstructured":"Bashir, Q., and Hamadani, M.C. (2019). Chapter 4\u2014The Role of Radiation Therapy in Hematopoietic Stem Cell Transplantation. Hematopoietic Cell Transplantation for Malignant Conditions, Elsevier."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102393","DOI":"10.1016\/j.eclinm.2023.102393","article-title":"Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: A prospective study of the EBMT Infectious Diseases Working Party","volume":"67","author":"Penack","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"ofz037","DOI":"10.1093\/ofid\/ofz037","article-title":"Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy","volume":"6","author":"Linder","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jcyt.2015.03.614","article-title":"Immune reconstitution after cord blood transplantation: Peculiarities, clinical implications and management strategies","volume":"17","author":"Lucchini","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.bbmt.2012.06.005","article-title":"Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation","volume":"18","author":"Kanda","year":"2012","journal-title":"Biol. Blood Marrow Transpl."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.2020005884","article-title":"How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease","volume":"136","author":"Champlin","year":"2020","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Franklin, A., Wurster, S., Axell-House, D.B., Jiang, Y., and Kontoyiannis, D.P. (2022). Impact of Hyperglycemia and Diabetes Mellitus on Breakthrough Mucormycosis Outcomes in Patients with Hematologic Malignancies-Complex and Intriguing Associations. J. Fungi, 9.","DOI":"10.3390\/jof9010045"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wurster, S., Cho, S.-Y., Allos, H., Franklin, A., Axell-House, D.B., Jiang, Y., and Kontoyiannis, D.P. (2024). Concordance of Chest Radiography and Chest Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?. J. Fungi, 10.","DOI":"10.3390\/jof10100703"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00405-021-06910-6","article-title":"Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis","volume":"279","author":"Horasan","year":"2022","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lary.23912","article-title":"Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidence","volume":"123","author":"Turner","year":"2013","journal-title":"Laryngoscope"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2500\/ajra.2017.31.4420","article-title":"Complete Surgical Resection and Short-Term Survival in Acute Invasive Fungal Rhinosinusitis","volume":"31","author":"Ishii","year":"2017","journal-title":"Am. J. Rhinol. Allergy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: Results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann. Thorac. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Potenza, L., Vallerini, D., Barozzi, P., Riva, G., Gilioli, A., Forghieri, F., Candoni, A., Cesaro, S., Quadrelli, C., and Maertens, J. (2016). Mucorales-Specific T Cells in Patients with Hematologic Malignancies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149108"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/myc.12431","article-title":"Natural killer cell-mediated damage of clinical isolates of mucormycetes","volume":"59","author":"Schmidt","year":"2016","journal-title":"Mycoses"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13693780701639546","article-title":"The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections","volume":"46","author":"Chamilos","year":"2008","journal-title":"Med. Mycol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"ofae103","DOI":"10.1093\/ofid\/ofae103","article-title":"Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience","volume":"11","author":"Lu","year":"2024","journal-title":"Open Forum Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/6\/423\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:25:53Z","timestamp":1781231153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/6\/423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jof12060423"],"URL":"https:\/\/doi.org\/10.3390\/jof12060423","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}